IRadimed Corporation
IRMD
$92.50
$1.291.41%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -10.31% | -9.69% | 15.52% | -3.42% | 23.19% |
| Total Depreciation and Amortization | -9.89% | 19.52% | -0.78% | 84.47% | 7.22% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 8.97% | -80.25% | 279.57% | -10.09% | -1.11% |
| Change in Net Operating Assets | -124.31% | 135.84% | -1,871.81% | -74.45% | 158.45% |
| Cash from Operations | -28.35% | 39.97% | -15.22% | -9.82% | 80.50% |
| Capital Expenditure | 54.09% | -36.98% | 74.14% | 56.84% | 28.70% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -290.91% | 45.99% | 2.94% | 33.03% | 14.55% |
| Cash from Investing | 5.54% | -12.63% | 67.05% | 55.25% | 27.90% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -368.00% | 97.84% | -7,735.14% | 69.17% | 17.24% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -0.04% | 70.12% | -295.56% | -0.07% | 0.05% |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -7.10% | 76.03% | -396.00% | 2.87% | 0.92% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -48.11% | 197.16% | -252.03% | 32.47% | 240.04% |